MKI67 and neoplasm: In this study we demonstrated that both Dox and AN-7 substantially reduce Ki-67 and c-Kit expression in the tumor and AN-7+Dox abolish it, supporting the notion that the combination treatment can potentially benefit treatment-resistance and aggressive tumors.